Competition is on the horizon for costly narcolepsy treatments
pharmaphorum
DECEMBER 14, 2022
But increased competition is on the horizon. Competition starts to heat up. In a case filed in California in 2021, Molina Healthcare claimed Jazz Pharmaceuticals engaged in a “comprehensive anticompetitive scheme to suppress generic competition for Xyrem,” abused the REMS program, and “engaged in sham patent litigation.”.
Let's personalize your content